Trial Profile
Open Label Randomised 3 Period Crossover Study to Evaluate Bioavailability of Modified Release Hydrocortisone (HC) Under Fasting & Fed Conditions & Immediate Release HC Tablets Under Fasting Conditions in Dexamethasone-suppressed Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Hydrocortisone (Primary) ; Dexamethasone
- Indications Adrenal insufficiency; Congenital adrenal hyperplasia
- Focus Pharmacokinetics
- Sponsors Diurnal
- 04 Apr 2017 Results presented at The 99th Annual Meeting of the Endocrine Society
- 08 Apr 2015 New trial record